I-Corps: A Home-based Solution for Remote Lung Function Monitoring for Patients with Chronic Lung Disease

I-Corps:慢性肺病患者远程肺功能监测的家庭解决方案

基本信息

  • 批准号:
    2341832
  • 负责人:
  • 金额:
    $ 5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-12-01 至 2024-11-30
  • 项目状态:
    已结题

项目摘要

The broader impact/commercial potential of this I-Corps project is the development of an improved measurement tool for remote lung function monitoring. Chronic lung disease impacts 10% of the United States population and nearly 80% of rural residents live in a "healthcare desert," with a limited number of overall healthcare providers, poor access to specialty care, large geographic distances between residents and hospitals, and socioeconomic challenges that provide barriers to accessing frequent care. Urban populations and U.S. veterans share many of these challenges. Current remote lung monitoring technologies lack sensitivity, effective reporting options and ease of use. Tools that leverage telemedicine in the lung health space along with higher-sensitivity lung monitoring tools have the potential to address these challenges. The proposed technology may provide the first head-to-head comparison of home-based gas washout technology, which is superior in the clinical setting, to standard-of-care home diagnostics and provide the rationale for future development of these technologies. The potential impact is high, given the large number of individuals that may benefit from improved home monitoring, physician dissatisfaction with current home-based solutions, and the number of patients that are currently underserved, including pediatric populations, rural populations, and underserved urban populations. This I-Corps project is based on the development of a solution for remote lung health monitoring. In the current healthcare model, most lung diagnostic measurements are made in the clinic or hospital. As a result, they are often made infrequently or in reaction to worsening symptoms. Spirometers and peak flow meters are widely available for home use but use forced exhalation maneuvers that are highly dependent on a patient's effort and can be highly variable. Gas washout methods sensitively and accurately measure the key elements of worsening lung disease - airway volume, airway homogeneity, and lung volume - that are recognized as superior to measurements based on forced exhalations. Until now, gas washout measurements have only been available in large medical centers because they require bulky equipment and externally supplied gases. To address these shortcomings, the proposed technology translates the principles underlying clinic-based gas washout to a home-based system, without the need for supplied gas tanks, and where measurement data can be reported back to a clinician’s office. Currently, home-based diagnostics are an insufficient supplement because home-based diagnostics include poorly sensitive methods, the requirement that patients keep a paper record, and the lack of integration of the information into the medical record. This technology may overcome these limitations by offering a superior diagnostic test that records data longitudinally and transmits these data to a clinician for review.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
该I-Corps项目的更广泛影响/商业潜力是开发用于远程肺功能监测的改进测量工具。慢性肺部疾病影响了10%的美国人口,近80%的农村居民生活在“医疗沙漠”中,整体医疗保健提供者数量有限,难以获得专科护理,居民和医院之间的地理距离很大,以及社会经济挑战,这些挑战为获得频繁护理提供了障碍。城市人口和美国退伍军人面临许多这些挑战。目前的远程肺部监测技术缺乏灵敏度、有效的报告选项和易用性。在肺部健康领域利用远程医疗的工具沿着更高灵敏度的肺部监测工具有可能解决这些挑战。所提出的技术可以提供基于家庭的气体冲洗技术的首次头对头比较,该技术在临床环境中上级标准护理家庭诊断,并为这些技术的未来发展提供依据。潜在影响很大,因为有大量的人可能受益于改善的家庭监测,医生对目前基于家庭的解决方案不满意,以及目前服务不足的患者数量,包括儿科人群,农村人群和服务不足的城市人群。这个I-Corps项目是基于远程肺部健康监测解决方案的开发。在当前的医疗保健模式中,大多数肺部诊断测量是在诊所或医院进行的。因此,它们通常不经常或对症状恶化作出反应。肺活量计和峰值流量计广泛用于家庭使用,但是使用高度依赖于患者努力并且可能高度可变的强制呼气操作。气体冲洗方法灵敏而准确地测量了肺部疾病恶化的关键因素-气道容积、气道均匀性和肺容积-这些因素被认为上级基于强制呼气的测量。到目前为止,气体冲洗测量仅在大型医疗中心可用,因为它们需要庞大的设备和外部供应的气体。为了解决这些缺点,所提出的技术将基于临床的气体冲洗的基本原理转化为基于家庭的系统,而不需要供应的气罐,并且其中测量数据可以报告回临床医生的办公室。目前,基于家庭的诊断是一个不足的补充,因为基于家庭的诊断包括敏感性差的方法,要求患者保持纸质记录,以及缺乏信息整合到医疗记录。这项技术可以克服这些限制,提供一个上级诊断测试,纵向记录数据,并将这些数据传输给临床医生进行审查。这个奖项反映了NSF的法定使命,并已被认为是值得通过使用基金会的智力价值和更广泛的影响审查标准进行评估的支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Tomasson其他文献

Clinical Factors Associated with Cytokine Release Syndrome and Dosing Recommendations for Restarting Elranatamab Following an Interruption
  • DOI:
    10.1182/blood-2023-182166
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Ruben Niesvizky;Bertrand Arnulf;Mohamad Mohty;Ajay K. Nooka;Salomon Manier;Michael Tomasson;Nizar J Bahlis;Donald Irby;Jennifer Hibma;Andrea Viqueira;Eric Leip;Alexander Lesokhin
  • 通讯作者:
    Alexander Lesokhin
OAB-026: MagnetisMM-1 study of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA) targeted CD3-engaging bispecific molecule, for patients (pts) with relapsed or refractory multiple myeloma (MM)
  • DOI:
    10.1016/s2152-2650(21)02100-5
  • 发表时间:
    2021-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Bhagirathbhai Dholaria;Nizar Bahlis;Noopur Raje;Caitlin Costello;Melhem Solh;Moshe Levy;Michael Tomasson;Harman Dube;Michael Damore;Hoi Kei Lon;Cynthia Basu;Athanasia Skoura;Edward Chan;Suzanne Trudel;Andrzej Jakubowiak;Michael Chu;Cristina Gasparetto;Andrew Dalovisio;Michael Sebag;Alexander Lesokhin
  • 通讯作者:
    Alexander Lesokhin
MM-379: MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM)
  • DOI:
    10.1016/s2152-2650(21)01978-9
  • 发表时间:
    2021-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Moshe Levy;Nizar Bahlis;Noopur Raje;Caitlin Costello;Bhagirathbhai Dholaria;Melhem Solh;Michael Tomasson;Harman Dube;Michael Damore;Hoi Kei Lon;Cynthia Basu;Athanasia Skoura;Edward Chan;Suzanne Trudel;Andrzej Jakubowiak;Michael Chu;Cristina Gasparetto;Andrew Dalovisio;Michael Sebag;Alexander Lesokhin
  • 通讯作者:
    Alexander Lesokhin
Long-Term Efficacy and Safety of Elranatamab Monotherapy in the Phase 2 Magnetismm-3 Trial in Relapsed or Refractory Multiple Myeloma (RRMM)
  • DOI:
    10.1182/blood-2023-182130
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Michael Tomasson;Shinsuke Iida;Ruben Niesvizky;Mohamad Mohty;Nizar J Bahlis;Joaquin Martinez-Lopez;Guenther Koehne;Paula Rodriguez Otero;H. Miles Prince;Andrea Viqueira;Eric Leip;Umberto Conte;Sharon T Sullivan;Alexander Lesokhin
  • 通讯作者:
    Alexander Lesokhin
Poster: MM-379: MagnetisMM-1: A Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA)-Targeted, CD3-Engaging Bispecific Antibody, for Patients with Relapsed or Refractory Multiple Myeloma (MM)
  • DOI:
    10.1016/s2152-2650(21)01578-0
  • 发表时间:
    2021-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Moshe Levy;Nizar Bahlis;Noopur Raje;Caitlin Costello;Bhagirathbhai Dholaria;Melhem Solh;Michael Tomasson;Harman Dube;Michael Damore;Hoi Kei Lon;Cynthia Basu;Athanasia Skoura;Edward Chan;Suzanne Trudel;Andrzej Jakubowiak;Michael Chu;Cristina Gasparetto;Andrew Dalovisio;Michael Sebag;Alexander Lesokhin
  • 通讯作者:
    Alexander Lesokhin

Michael Tomasson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Automating data acquisition and data processing pipeline via artificial intelligence and machine learning approaches to allow at-home use of a novel breast cancer screening method employing bra-based elastography imaging.
通过人工智能和机器学习方法自动化数据采集和数据处理流程,以便在家使用基于胸罩的弹性成像成像的新型乳腺癌筛查方法。
  • 批准号:
    486956
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Operating Grants
SBIR Phase I: A home-compostable replacement to petroleum-based flexible packaging derived from seaweed
SBIR 第一阶段:以海藻为原料的石油基软包装的家庭可堆肥替代品
  • 批准号:
    2302043
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
I-TRANSFER-HF: Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe: A Type 1 Hybrid Effectiveness Implementation Trial
I-TRANSFER-HF:改善家庭医疗保健中心力衰竭患者的过渡和结果:1 型混合有效性实施试验
  • 批准号:
    10714524
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
Impact of Alcohol Home Delivery on Access, Consumption, and Exposure to Marketing
酒类送货上门对获取、消费和营销曝光的影响
  • 批准号:
    10727955
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
Kipiyecipakiciipe "coming home": Establishing clinical cultural neuroscience as a tool for understanding the role of traditional cultural engagement in mitigating substance misuse and disorder
Kipiyecipakiciipe“回家”:建立临床文化神经科学作为理解传统文化参与在减轻药物滥用和疾病中的作用的工具
  • 批准号:
    10740237
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
Home Alone: Developing a Home-Based Intervention for People with Cognitive Impairment Who Live Alone
独自在家:为独居认知障碍患者制定家庭干预措施
  • 批准号:
    10590347
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
Development of an experience-based end-of-life learning model for visiting caregivers to support EOL care at home
为探访护理人员开发基于体验的临终学习模型,以支持家庭生命终止护理
  • 批准号:
    23K10300
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Modelling the Future of Home Health for Seniors - A Markov based Cost Effectiveness Analysis
模拟老年人家庭健康的未来 - 基于马尔可夫的成本效益分析
  • 批准号:
    484653
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Fellowship Programs
Maximizing the Value of VA Homemaker/Home Health Aide (H/HHA) Services to Veterans, Caregivers and VA: Supporting Older Veterans’ Pathways to Stable H/HHA Care
最大限度地发挥 VA 家庭主妇/家庭健康助理 (H/HHA) 服务对退伍军人、护理人员和 VA 的价值:支持老年退伍军人 — 获得稳定 H/HHA 护理的途径
  • 批准号:
    10638592
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson's Disease Trials-2 (AT-HOME PD-2)
评估帕金森病多年扩展试验中的远程医疗结果 Trials-2 (AT-HOME PD-2)
  • 批准号:
    10658165
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了